Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Finasteride can cause melasma, especially in people with darker skin.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Certain alkaloids could help create new coronavirus drugs.

Baricitinib works better than methotrexate for severe alopecia areata.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.